Am J Psychiatry 1985; 142:1017-1031
Copyright © 1985 by American Psychiatric Association
Overview: toward a dysregulation hypothesis of depression
LJ Siever and KL Davis
The authors suggest that the activity of neurotransmitter systems in the
affective disorders and related psychiatric syndromes may be better
understood as a reflection of a relative failure in their regulation,
rather than as simple increases or decreases in their activity. A model
organized around the concept of "dysregulation" posits that persistent
impairment in one or more neurotransmitter homeostatic regulatory
mechanisms confers a trait vulnerability to unstable or erratic
neurotransmitter output. Evidence from clinical and animal model studies
for dysregulation of the noradrenergic system in depression is examined
with respect to criteria generated by such a general model, and a specific
configuration of noradrenergic dysregulation in some forms of depression is
proposed.
This article has been cited by other articles:
|
|
|
|
 
R. A. Bermudes, P. E. Keck Jr., and J. A. Welge
The Prevalence of the Metabolic Syndrome in Psychiatric Inpatients With Primary Psychotic and Mood Disorders
Psychosomatics,
December 1, 2006;
47(6):
491 - 497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Giese-Davis, F. H. Wilhelm, A. Conrad, H. C. Abercrombie, S. Sephton, M. Yutsis, E. Neri, C. B. Taylor, H. C. Kraemer, and D. Spiegel
Depression and stress reactivity in metastatic breast cancer.
Psychosom Med,
September 1, 2006;
68(5):
675 - 683.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Carney, K. E. Freedland, and R. C. Veith
Depression, the Autonomic Nervous System, and Coronary Heart Disease
Psychosom Med,
May 1, 2005;
67(Supplement_1):
S29 - S33.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Reynolds, T. A. Ignatowski, R. Sud, and R. N. Spengler
Brain-Derived Tumor Necrosis Factor-{alpha} and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
1216 - 1225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Rajkowski, H. Majczynski, E. Clayton, and G. Aston-Jones
Activation of Monkey Locus Coeruleus Neurons Varies With Difficulty and Performance in a Target Detection Task
J Neurophysiol,
July 1, 2004;
92(1):
361 - 371.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Lustman and R. E. Clouse
Section III: Practical Considerations in the Management of Depression in Diabetes
Diabetes Spectr,
July 1, 2004;
17(3):
160 - 166.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ramaswamy, E. Dahl, S. P. Sattar, and F. Petty
Sotalol-induced depression
Ann. Pharmacother.,
July 1, 2004;
38(7):
1321 - 1322.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Mitterauer
Imbalance of Glial-Neuronal Interaction in Synapses: A Possible Mechanism of the Pathophysiology of Bipolar Disorder
Neuroscientist,
June 1, 2004;
10(3):
199 - 206.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. S. Lett, J. A. Blumenthal, M. A. Babyak, A. Sherwood, T. Strauman, C. Robins, and M. F. Newman
Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment
Psychosom Med,
May 1, 2004;
66(3):
305 - 315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Peeters, N. A. Nicholson, and J. Berkhof
Cortisol Responses to Daily Events in Major Depressive Disorder
Psychosom Med,
September 1, 2003;
65(5):
836 - 841.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Carney, K. E. Freedland, P. K. Stein, L. L. Watkins, D. Catellier, A. S. Jaffe, and V. K. Yeragani
Effects of Depression on QT Interval Variability After Myocardial Infarction
Psychosom Med,
March 1, 2003;
65(2):
177 - 180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Shaffery, R. Hoffmann, and R. Armitage
The Neurobiology of Depression: Perspectives from Animal and Human Sleep Studies
Neuroscientist,
February 1, 2003;
9(1):
82 - 98.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. C. Sirois and M. M. Burg
Negative Emotion and Coronary Heart Disease: A Review
Behav Modif,
January 1, 2003;
27(1):
83 - 102.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. M. Carney, J. A. Blumenthal, P. K. Stein, L. Watkins, D. Catellier, L. F. Berkman, S. M. Czajkowski, C. O'Connor, P. H. Stone, and K. E. Freedland
Depression, Heart Rate Variability, and Acute Myocardial Infarction
Circulation,
October 23, 2001;
104(17):
2024 - 2028.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Raikkonen, K. A. Matthews, and L. H. Kuller
Trajectory of Psychological Risk and Incident Hypertension in Middle-Aged Women
Hypertension,
October 1, 2001;
38(4):
798 - 802.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Jonas and M. E. Mussolino
Symptoms of Depression as a Prospective Risk Factor for Stroke
Psychosom Med,
July 1, 2000;
62(4):
463 - 471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Davidson, B. S. Jonas, K. E. Dixon, and J. H. Markovitz
Do Depression Symptoms Predict Early Hypertension Incidence in Young Adults in the CARDIA Study?
Arch Intern Med,
May 22, 2000;
160(10):
1495 - 1500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Carney, K. E. Freedland, R. C. Veith, and A. S. Jaffe
Can Treating Depression Reduce Mortality After an Acute Myocardial Infarction?
Psychosom Med,
September 1, 1999;
61(5):
666 - 675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Berman, M. Narasimhan, H. L. Miller, A. Anand, A. Cappiello, D. A. Oren, G. R. Heninger, and D. S. Charney
Transient Depressive Relapse Induced by Catecholamine Depletion: Potential Phenotypic Vulnerability Marker?
Arch Gen Psychiatry,
May 1, 1999;
56(5):
395 - 403.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Paterniti, A. Alperovitch, P. Ducimetiere, M.-J. Dealberto, J.-P. Lepine, and J.-C. Bisserbe
Anxiety But Not Depression Is Associated With Elevated Blood Pressure in a Community Group of French Elderly
Psychosom Med,
January 1, 1999;
61(1):
77 - 83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Mendes de Leon, H. M. Krumholz, T. S. Seeman, V. Vaccarino, C. S. Williams, S. V. Kasl, and L. F. Berkman
Depression and Risk of Coronary Heart Disease in Elderly Men and Women: New Haven EPESE, 1982-1991
Arch Intern Med,
November 23, 1998;
158(21):
2341 - 2348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.B. Kelly and S.J. Cooper
Differences and variability in plasma noradrenaline between depressive and anxiety disorders
J Psychopharmacol,
January 1, 1998;
12(2):
161 - 167.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Gorenstein, V. Gentil, M. Melo, F. Lotufo-Neto, and V. Lauriano
Mood improvement in 'normal' volunteers
J Psychopharmacol,
January 1, 1998;
12(3):
246 - 251.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. L. Miller and L. Ereshefsky
Schizophrenia: how should we look at it?
J Psychopharmacol,
January 1, 1997;
11(1):
21 - 23.
[PDF]
|
|
|
|
|
|
|
L. A. Pratt, D. E. Ford, R. M. Crum, H. K. Armenian, J. J. Gallo, and W. W. Eaton
Depression, Psychotropic Medication, and Risk of Myocardial Infarction: Prospective Data From the Baltimore ECA Follow-up
Circulation,
December 15, 1996;
94(12):
3123 - 3129.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. A. Genovese, M. K. Libbus, and M. J. Poole
Organized Aerobic Exercise and Depression in Male County Jail Inmates
Journal of Correctional Health Care,
April 1, 1995;
2(1):
5 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. K. Libbus, J. A. Genovese, and M. J. Poole
Organized Aerobic Exercise and Depression in Male County Jail Inmates
Journal of Correctional Health Care,
October 1, 1994;
1(1):
5 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. K. Libbus, J. A. Genovese, and M. J. Poole
Organized Aerobic Exercise and Depression in Male County Jail Inmates
Journal of Correctional Health Care,
January 1, 1994;
1(2):
5 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Grossman, H. K. Manji, and W. Z. Potter
Platelet {alpha}2-adrenoreceptors in depression: a critical examination
J Psychopharmacol,
January 1, 1993;
7(1_suppl):
4 - 18.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. J. Nutt and P. Glue
Imipramine in panic disorder. 2. Effects on {alpha}2-adrenoceptor function
J Psychopharmacol,
January 1, 1991;
5(2):
135 - 141.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. K. Laird and J. J. Saklad
Attention-Deficit Hyperactivity Disorder
Journal of Pharmacy Practice,
January 1, 1990;
3(4):
241 - 251.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Glue, D. Nutt, and P. Glue
Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication
J Psychopharmacol,
January 1, 1988;
2(3-4):
119 - 137.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Healy
The comparative psychopathology of affective disorders in animals and humans
J Psychopharmacol,
January 1, 1987;
1(3):
193 - 210.
[Abstract]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1985
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
